Linked to Amputation and Fournier's Gangrene
Injuries linked to SGLT2 Inhibitors include:
Lower Limb Amputation
The FDA has Warned of Safety Risks
Along with the 2018 warning about Fournier’s gangrene there have been numerous other warnings.
2017 – FDA required a black box warning on Invokana, Invokamet and Invokamet XR,regarding the increased risk of leg and foot amputations.
2016 – FDA strengthens warnings regarding the risk of acute kidney injury.
2015 – FDA warned of SGLT2 Inhibitors causing too much acid in the blood, serious urinary tract infections and ketoacidosis.
Numerous lawsuits against the manufacturers of SGLT2 drugs have be brought by injured patients nationwide seeking financial compensation.
Do not stop taking any medication without speaking with your health care professional.
Know Your Rights
For over 75 combined years, our legal team has successfully helped thousands of victims and families. If you or a loved one experienced injuries while using Invokana® or SGLT2 Inhibitors, call us at 877-535-5750 or fill out the form for a free consultation.